Background: Endotoxemia in pediatric cardiac surgical patients is poorly understood. The endotoxin activity assay (EAA) levels were examined in neonates undergoing cardiac surgery in order to assess their reference levels and their association with other pre-, intra-, and postoperative risk factors for gut hypoperfusion. We finally observed if refeeding was associated with modification of endotoxin levels. Methods: In a prospective cohort study, neonates undergoing surgery for correction or palliation were enrolled. Preterm birth, weight below 1.5 kg, the need for extracorporeal membrane oxygenation, and urgent surgery were exclusion criteria. Results: Among the 26 enrolled neonates, 12 underwent on-pump and 14 off-pump surgery, 22 received a preoperative infusion of prostaglandin E2. Overall, 11 patients were surgically corrected and 15 received a palliation. Endotoxin activity assay baseline levels were inversely correlated with age at surgery (r ¼ À.50, P ¼ .006) and they increased to postoperative day2 (P ¼ .002). On-pump versus off-pump surgery (P ¼.36) and surgical palliation with a Blalock-Taussig shunt versus correction (P ¼ .45) did not predict increase in EAA levels. Aortic clamping for coarctation repair was associated with the lowest levels (P ¼ .04). Systolic, mean, and diastolic pressures were associated with EAA levels (r ¼ À.55, P ¼ .01; r ¼ À.45, P ¼ .02; r ¼ À.37, P ¼ .04, respectively). Endotoxin activity assay levels after refeeding were similar to baseline levels. Patients with abdominal distension and feeding intolerance showed higher median peak EAA levels (0.7, 0.66-1.11) than asymptomatic patients (0.53, 0.35-0.64; P ¼ .01). Conclusions: Endotoxin activity assay levels increase after elective neonatal surgery and are not modified by refeeding. High postoperative levels may predict feeding intolerance.
Introduction
The etiology and pathogenesis of endotoxemia in pediatric cardiac surgical patients is poorly understood, and its role on clinical outcomes yet to be clarified. 1, 2 Endotoxemia in postsurgical patients has been described as secondary to intestinal translocation, due to mesenteric ischemia during the intraoperative phase. Splanchnic hypoperfusion is a common finding in children during and following cardiac surgery, 3 and it is considered secondary to nonpulsatile cardiopulmonary bypass (CPB) perfusion, 4 patients' underlying cardiac anatomy, perioperative cyanosis, and perioperative hemodynamic instability. 5 All these factors may cause damage to the mucosal barrier, allowing endotoxin translocation. Systemic endotoxin concentrations also correlate closely with the degree of cardiovascular dysfunction following cardiac surgery 6 and may predict poor outcome. 1, 7 However, other authors found no association between mucosal acidosis and either endotoxemia or intestinal permeability. 8 We have previously shown an association between endotoxin activity assay (EAA) levels and several clinical variables (ie, CPB length and vasoactive drugs doses) in a cohort of infants with congenital heart disease (CHD) undergoing surgery with CPB. 2 In that study, we also noticed that the small subgroup of 6 neonates was associated with higher EAA levels.
Neonatal baseline EAA levels can be theoretically higher in the first days of life with respect of older populations: This aspect could be explained, especially in preterm and low birth weight babies by the immaturity of gut mucosal barrier and neonatal immune system. 9 Postcardiac surgery neonates have several specific risk factors for gut hypoperfusion in addition to potential CPB-related mesenteric underperfusion [10] [11] [12] : The presence of a ductal-dependent anatomy in patients with univentricular anatomy or pulmonary/aortic hypoplasia/atresia require pulmonary or systemic circulation via the ductus arteriosus (DA). 13 A similar pathophysiological picture is represented by the palliation with a systemic to pulmonary Blalock-Taussig (BT) shunt which is required in specific neonatal diagnoses. Such patients are considered at risk of mesenteric ischemia due to a potentially low diastolic pressure secondary to diastolic runoff into the pulmonary circulation. Similarly, bowel hypoperfusion might occur in the perioperative phase in patients with aortic coarctation. Furthermore, a particularly critical phase for mesenteric perfusion in neonates with CHD is postoperative refeeding. Although no high-level recommendation exists in the cardiac surgery population about when patients can receive enteral nutrition in the postsurgical period, it might be speculated that intestinal function (and eventual translocation) can be affected by intraoperative events, mainly by ischemic pathophysiology. 14 The aim of the present study was to increase our knowledge about EAA perioperative levels, in the specific population of neonates with CHD undergoing cardiac surgery, by exploring variables potentially related to splanchnic perfusion (presence of CPB, shunt-dependent circulation or aortic coarctation, postoperative hemodynamics, and available perfusion indexes) and splanchnic function (postoperative refeeding and feeding intolerance).
Patients and Methods

Study Design
A prospective observational monocentric cohort study was conducted. Consecutive neonates undergoing surgery for CHD correction or palliation were enrolled. Inclusion criteria were age younger than 1 month and need for surgery. Exclusion criteria were preterm birth (before 35 weeks), very low birth weight (below 1.5 kg), preoperative diagnosed or suspected infection, the need for extracorporeal membrane oxygenation or a ventricular assist device at any perioperative phase, surgery for heart transplantation, and/or urgent surgery. The institutional review board approved the study.
Demographic data (age, weight, diagnosis, Aristotle score, and need and duration of prostaglandin E1 infusion) were collected after enrollment. Surgical data were collected after the procedure (surgical procedure, CPB duration, need for deep hypothermic circulatory arrest [ [CRP] ) were collected at baseline, at POD 1 and 2. The EAA was also collected 24 hours after the first administration of postoperative enteral refeeding. Institutional protocol of neonatal feeding (except specific cases that are discussed for protocol deviation) prompts early preoperative patient enteral nutrition in case of patients with spontaneous breathing, hemodynamic stability without systemic ductal-dependent circulation, and elective surgery scheduled later than the first three days after birth. According to this protocol, in the postoperative phase, enteral nutrition is generally administered after extubation if hemodynamics is stable, and there is no need for noninvasive ventilation. Enteral nutrition is interrupted in case of feeding intolerance and, after symptoms subside, refeeding is achieved with slow progressive administration of small amounts of hydrolized milk (with alternate days stepped increases, according to patients' symptoms). Feeding intolerance is defined as clear symptoms of abdominal pain with specific recurrence after at least two failed milk administration attempts associated with abdominal distension (and meteoric bowel loops confirmed at X-rays). Regardless of enteral feeding, parenteral nutrition is prescribed to all neonates expected to require more than 2 postoperative PCICU days.
If signs of infection (fever, elevated WBC count, neutrophils, and CRP) were observed, urine and blood cultures were sent. Length of mechanical ventilation (LMV) and length of stay (LOS) were also recorded.
Endotoxin activity assay was analyzed within one hour from blood withdrawal (1 mL) and stored in EDTA vials. Endotoxin in whole blood was measured as recommended by the manufacturer (Spectral Diagnostics, Toronto, Ontario, Canada). 15 Endotoxin activity assay methodology includes sampling of 50 mL of whole blood, according to standard procedure. An EAA level of 0.4 is approximately equivalent to an endotoxin concentration of 25 to 50 pg/mL Escherichia coli 055: B5 LPS. A level of <0.4 is defined as low, a level of 0.41 to 0.59 is defined as intermediately elevated, and a level of >0.6 is defined as highly elevated. The results are provided with a CV that is a measure of precision: a CV up to 30% is considered adequate in cases of EAA <0.2 and a CV up to 15% when EAA is >0.2. All other blood measurements utilized for this study were originally requested for routine clinical practice and were not specifically ordered in the light of the present observational trial.
Cardiopulmonary bypass was always conducted with alpha stat strategy and blood cardioplegia. A CPB flow of 150 mL/ kg/min, a hematocrit of 28% to 30%, and moderate hypothermia with the temperature ranging between 25 C and 32 C were targeted. Aortic cross clamping during CPB was performed when intracardiac surgery was required. When DHCA was indicated, perfusion temperature was lowered to 18 C and CPB arrested thereafter. Off-pump surgery was conducted every time extracardiac surgery allowed hemodynamic stability (aortic decoarctation and BT shunt placement in patients with adequate pulmonary flow). Antibiotic prophylaxis included the administration of cefoxitin 40 mg/kg intravenously for up to POD2.
Adequate previous information on average EAA in a cohort of pediatric cardiac surgery neonates is currently lacking; hence, an exploratory study was designed, planned to last about six months. The institutional review board approved the design of the study. Informed consent was obtained from patients' parents before surgery.
The primary objective of this study was the evaluation of endotoxin levels in consecutive neonates scheduled for elective surgery (both "on-" and "off-pump") through the serial measurement of EAA in the perioperative phase.
The secondary objectives were (1) to verify the association between EAA levels and presence of preoperative pulmonary or systemic ductal circulation, days of age at surgery, need for CPB or DHCA, need for aortic cross clamping, placement of a BT shunt, VIS, lactates, and creatinine levels at the end of surgery, CRP, and systemic arterial pressure (all potentially related to splanchnic hypoperfusion) and (2) to verify the modification of EAA levels after postoperative enteral feeding start (including patients with signs of feeding intolerance) with respect to baseline levels.
The association of EAA levels modification with outcome variables (postoperative positive hemocultures or broncoalveolar lavages, MV duration, and PCICU length of stay) were also assessed even if this observational study was not powered on such aim.
Statistical Analysis
The Mann-Whitney U test was used to compare continuous variables. Analysis of variance for repeated measures of nonparametric samples (Kruskal Wallis test) was used to assess parameters over time. Dunns posttest was used to identify significant differences at different time points. Spearman correlation was used to analyze the associations of EAA with continuous variables. In case of categorical variables (ie, coarctation vs no coarctation), Mann-Whitney U test and differences between medians with 95% confidence interval (yes À no) were used to show the association between EAA levels in groups with and without the categorical variable. The area under the receiver-operating characteristics curve (AUC ROC) was used to evaluate EAA as a diagnostic test for abdominal distension after refeeding. All data are presented as median (interquartile range [IQR]). A P value <.05 was considered significant. Statistical analysis was performed with the GraphPad Prism 5.0 software package (Graph-Pad Software, San Diego, California) and with StatsDirect statistical software (Cheshire, United Kingdom).
Results
Overall, 26 term-born neonates were enrolled. Patients' diagnoses, demographic, and surgical characteristics are depicted in Table 1 . In brief, 12 neonates underwent CPB (of which 6 required deep hypothermic circulatory arrest for aortic arch reconstruction) and 14 underwent off-pump surgery (of these, 6 underwent aortic clamping for coarctation repair). Twentytwo patients received preoperatively an infusion of prostaglandin E2 for ductal patency. Overall, 11 patients were surgically corrected and 15 received a palliation. Seven patients had univentricular anatomy. All patients survived to PCICU discharge.
The EAA levels increased from baseline to POD2 (P ¼ .002) with respect to baseline levels and to POD 1 ( Figure 1A) . Five of 104 analyzed EAA samples were discarded and resampled due to exceeded CV limits (in three cases resampling was possible in leftover blood from the initial withdrawal). The CVs tended to decrease from baseline to POD2 as expected by quality control ( Figure 1B) . Interestingly, EAA levels exceeding 0.6 were almost exclusively identified at POD 2 (baseline, n ¼ 1; POD 1, n ¼ 2; POD2, n ¼ 10; and refeeding, n ¼ 1), whereas low severity EAA values (<0.4) were found in the relative (%) minority of neonates, at all time points (baseline 50%; POD 1 34%; POD2 23%; and refeeding: 31%; Figure  1C ). C-reactive protein showed, over time, similar relative modifications with respect to EAA (Figure 2A ). Baseline EAA levels appeared to have a significant correlation with age of patients at surgery, with the highest values in the youngest neonates (r ¼ À.50, P ¼ .006). When baseline features of the six patients who received enteral nutrition before surgery were compared to those who did not, we noticed that they were older (median No differences in EAA levels at POD2 were noticed between the 12 patients who underwent CPB and 14 patients with off-pump surgery (median difference 0.06, P ¼ .36; Table 2 ). However, the six patients who required aortic clamping for coarctation repair displayed the lowest EAA levels at POD2, compared to the others (median difference À0.3, P ¼ .04; Table 2 ). Ten patients received a surgical palliation with a BT shunt providing pulmonary flow from systemic circulation (two of them required CPB use). These patients did not show a higher risk of elevated EAA levels at POD 2 (median difference 0.09, P ¼ .45; Table 2 ). Similarly, the presence of preoperative pulmonary or systemic ductal circulation, the use of DHCA, VIS, lactates, cNIRS at POD1, creatinine, urine output, WBC count, and CRP concentration at the end of surgery were not associated with EAA levels at any time point (Table 3) . However, systolic arterial pressure (SAP), mean arterial Figure 1 . A, Endotoxin activity assay (EAA) levels over the study time points of the 26 enrolled patients: at baseline (Basel), which was considered as the morning when surgery was scheduled; postoperative day 1 (POD1): the morning after surgery; POD2: the other day after surgery; ReFeed: 24 hours after enteral nutrition was re-administered postoperatively and full or almost complete realimentation was achieved. Data expressed as median and range. *P ¼ .002 at Kruskal Wallis test. B, Coefficients of variation (CV) over the study time points of the 26 enrolled patients. EAA test is considered accurate when CV is around 20% for levels below 0.4 and around 10% for levels above 0.4. Accordingly, the highest median CVs were reported at baseline, where the majority of patients had low EAA levels. C, Relative percentage distribution of the 3 EAA severity classes (>0.6, between 0.4 and 0.6, and <0.4) and its modification over time. The absolute number of patients categorized by each EAA class are reported within the columns. pressure (MAP), and diastolic arterial pressure (DAP) were associated with EAA levels at POD 1 (r: À.55, P ¼ .01; r:À.45, P ¼ .02; r: À.37, P ¼ .04, respectively). At POD2, SAP, MAP, and DAP associations were still present although less significant (r: À.34, P ¼ .10; r:À.30, P ¼ .11; r: À.24, P ¼ .2). The inverse correlation between arterial pressures and EAA was lost after refeeding (data not shown). Patients with BT shunt tended to have lower PAD at POD2 (r ¼ À4.0; P ¼ .052).
Four patients were evaluated with hemocultures that resulted negative in all cases. The levels of EAA at POD 2 did not correlate with LMV (r: .27, P ¼ .2) and with PCICU LOS (r: .38, P ¼ .08).
Before PCICU discharge, 18 patients of 26 were already receiving enteral nutrition. Nutrition with artificial milk was started after a median postsurgical time of five (4-7) days. In all these patients, the EAA levels appeared to be significantly reduced, with respect to POD2 values, after enteral refeeding (EAA median difference with POD2 À0.15, P ¼ .01), without significant differences compared to baseline levels (EAA median difference 0.06, P ¼ .6). However, three (11.5%) patients showed abdominal distension and pain after milk administration (a patient corrected for transposition of the great arteries (TGA), a patient who underwent a hybrid procedure and a Norwood patient). An abdomen X-ray confirmed bowel loops distension and feeding intolerance. Median (IQR) EAA at POD2 in these patients was 0.7 (0.66-1.11): In the remaining asymptomatic patients at refeeding, median (IQR) EAA values were 0.53 (0.35-0.64; P ¼ .01). The AUC ROC of EAA at POD2 for the diagnosis of abdominal distension after refeeding was 0.9 (P ¼ .02). No patient with abdominal distension showed elevated CRP levels at POD2 (P ¼ 0.2; Figure 2B ). Similarly, all parameters of systemic perfusion (systemic pressure, lactates, and cNIRS) were comparable between patients with and without feeding intolerance (data not shown). Median (IQR) EAA levels of patients with feeding intolerance measured at the realimentation time point were comparable with asymptomatic ones (0. P ¼ .9). Slow refeeding with hydrolyzed milk was successful in all these cases in a median (IQR) period of seven (5-8) days.
Comment
The key messages of this study are (1) baseline EAA levels in the neonatal population are averagely high, and they show an inverse correlation with age at surgery (and preoperative feeding); (2) surgery induces a significant increase in EAA levels that peak at POD2 regardless of the presence of CPB; (3) systemic to pulmonary diastolic runoff is not significantly associated with EAA levels, whereas systemic arterial pressure seems to be lower in patients with higher EAA values; and (4) refeeding does not cause any EAA increase but the highest EAA levels at POD2 may be predictors of feeding intolerance.
Our group previously showed that in infants (including a small subgroup of 6 neonates) undergoing CPB EAA peaked at POD 2: we speculated that such delayed increases might be secondary to inadequate organ perfusion (likely intraoperative) and subsequent intestinal translocation, justifying this lag of 48 hours from surgery to EAA peak. 2 In the present study, we decided to exclusively focus on neonates with CHD, and we showed that, starting from baseline, they represent a peculiar population with the majority of EAA levels above the "normal" range. The reasons for this aspect may be due to immaturity of gut mucosal barrier and neutrophil activation that triggered their positive reaction to this assay. 9, 16 As a confirmation, we noticed that neonatal baseline EAA levels looked already high, especially in the very first days of life, before any surgical trigger. Preoperative enteral feeding was also a variable associated with reduced baseline preoperative EAA levels; however, age and preoperative feeding did not appear to have an impact on subsequent postoperative EAA levels. This observation on baseline levels was not found in our previous study conducted on averagely older patients. 2 In this light, none of preselected variables clinically related to gut hypoperfusion (the presence of a shunt dependent circulation, duration of CPB and aortic cross clamp, the use of DHCA, and the dose of vasoactive drugs) showed a significant and specific association (or they all acted similarly). However, we observed that shorter off-pump surgeries (coarctation repair), although at significant risk of splanchnic ischemic damage secondary to the aortic cross clamp during coarctation resection, were instead those with the lowest postoperative EAA levels. In these elective cases, the time elapsed with hemodynamic derangement was significantly limited and exposure to the inflammatory cascade of CPB was avoided. Different results may be found in patients with undiagnosed ductal-dependent coarctation and cardiac dysfunction who are referred to urgent surgery with signs of splanchnic ischemia and/or more prolonged surgical times. As a matter of fact, arterial pressure decrease showed some correlation with EAA increase, even if other common indexes of organ perfusion were not correlated.
Overall, basing on (indirect) variables of gut perfusion, it appeared very difficult to clearly predict EAA in cardiac neonates. The impact of generally elevated EAA levels may also dilute out the predictive power with respect to hard outcomes as VIS, LMV, and PCICU LOS, differently from what previously shown in infants 2, 6 Interestingly, the behavior of CRP, routinely utilized in our department as an aspecific marker of systemic inflammation, was very similar to EAA. We have to acknowledge that, although an important issue, no biomarker or other gold standard reference is currently routinely available for direct "gut barrier failure" assessment. Intestinal permeability can be evaluated noninvasively by measuring urinary excretion ration of orally administered water-soluble, nondegradable test molecules 14 : Lactulose is assumed to be absorbed paracellularly and rhamnose or mannitol transcellularly. Intestinal permeability is considered to be normal if the urinary lactuloserhamnose or lactulose-mannitol ratio is below 0.05 or 0.09, respectively. This method showed that in adults CPB affects gut perfusion regardless of intraoperative hemodynamics, 17 that CPB affects neonatal intestinal permeability after cardiac surgery extending to at least postop day 14, 14 and that children undergoing repair of aortic coarctation show the fastest recovery of intestinal permeability. 18 There has been criticism concerning the interpretation and significance of the permeability tests due to the fact that they may be affected by patients' fluid loading and by preabsorption factors (gastric emptying, dilution by secretion and intestinal transit time) and postabsorption factors (systemic distribution and renal clearance). 18 The available serum biomarkers such as plasma citrulline, a biomarker of functional enterocyte mass, and plasma or urinary intestinal fatty acid-binding protein (IFABP), a marker of enterocyte damage, 3, 19 are currently not available as point-of-care tests. Furthermore, although some literature is available for these biomarkers, the thresholds of their serum concentrations still requires careful interpretation and is subject to error. 19 Finally, similar to what is described in this study, extreme reductions in plasma citrulline and elevated increases in IFABP are more specifically related to enterocyte damage. 20, 21 In our cohort, no episode occurred of necrotizing enterocolitis (NEC), the most threatening consequence of neonatal gut ischemia 12 : NEC may be responsible for states of severe inflammation, sepsis, and endotoxemia through intestinal bacterial translocation. The condition of feeding intolerance may have insidious clinical courses and, in some cases, may be considered a form of subclinical NEC. In both cases, diagnosis is not specific nor easily performed as the clinical signs (abdominal distension and pain, dilated bowel loops at X-ray, and blood-stained stools) are elusive. 10 In our cohort, three patients showed nonspecific and transitory bowel dysfunction after refeeding (feeding intolerance): These children underwent significantly different (major) surgeries, with and without CPB, and showed extremely elevated EAA peak value at POD2. We might speculate that in these cases gut perfusion was particularly affected due to particularly complex surgeries. Again, feeding intolerance appeared very difficult to predict, as these patients (although the small number prevented any reliable statistical evaluation) did not show significant differences with the asymptomatic cohort as far as perfusion parameters were concerned. As a matter of fact, however, EAA levels peaking to about 0.7 may be considered predictive of nutrition intolerance. Finally, the measurement of EAA after the administration of enteral nutrition showed a restoration of baseline levels that, apparently, were not affected by the reactivation of bowel function.
Limitations
The main limitation of this prospective study was that a small sample size was enrolled. It must be highlighted however that the choice of including only patients undergoing neonatal surgery significantly limited the enrollment rate. Furthermore, although the study was prospective and observational, we were able to include neonates with different diagnoses, and we had the possibility of comparing several subgroups of patients. It has to be acknowledged, however, that the analysis of these subgroups should be further confirmed in significantly larger samples. Another important limitation of this study is that we hypothesized to associate EAA test with indirect clinical parameters of bowel hypoperfusion. As such, given the absence of significant associations in our study, we cannot now conclude if the EAA test is not accurate or is not helpful as a marker of gut hypoperfusion in neonates. In any case, however, based on our results, its use may be further evaluated by limiting sampling to specific cohorts or to POD2 (when the peak values are reached). Furthermore, it cannot be excluded that a more detailed assessment of organ perfusion and/or cardiac function (analysis of arterial pressures in prolonged periods-not at static time points-and/or the assessment of abdominal NIRS or cardiac index) might provide more consistent data as far as gut perfusion is concerned. A third important limitation of this study was the absence, within enrolled sample, of patients with established NEC. As a matter of fact, this is a rare and devastating condition, which more commonly occurs in patients undergoing urgent procedures (ie, for severe cyanosis or hemodynamic instability) or neonates with very low birth weight at birth or extreme prematurity 22 : both these conditions were excluded in this study in order to collect information from elective cases.
Conclusions
In conclusion, EAA levels in elective postcardiac surgery neonates peak 48 hours postoperatively and are not apparently modified after refeeding. Although neonates' age, systemic pressure, and surgery complexity were associated with postoperative EAA levels, preselected variables of indirect gut perfusion appeared not to be predictive. Postoperative EAA levels above 0.6 may predict feeding intolerance.
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